Opinion
- Author:
- Andrew M. Kaunitz, MD
Publish date: May 15, 2024
Study results provide further evidence to support the possibility that agents that reduce nighttime hot flashes (including hormone therapy) may low...
Opinion
- Author:
- Andrew M. Kaunitz, MD
Publish date: September 18, 2023
Concomitant use of vaginal estrogen and aromatase inhibitors was associated with a higher risk for breast cancer recurrence than was use of vaginal...
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: June 9, 2022
If precedents set in Roe v Wade are overturned, ObGyns have several immediate and long-term challenges<...
Opinion
- Author:
- Andrew M. Kaunitz, MD
Publish date: April 12, 2022
Because reproductive-aged women represent a population in which migraines are prevalent, clinicians need guidance to help women taking topiramate m...
Opinion
- Author:
- Andrew M. Kaunitz, MD
Publish date: April 19, 2021
It may be reasonable to steer high-risk reproductive-age women away from the J&J vaccine in favor of the Moderna and Pfizer vaccines, if these ...
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: February 4, 2021
Analysis of data from a large cross-sectional cohort and national databases that included almost 257,000 women indica...
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: November 3, 2020
The use of combined oral contraceptives (COCs) in 119 women with a mean age of 30.3 years who had premature o...
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: August 18, 2020
An analysis of observational data from 76,630 women included in a breast cancer registry in Victoria, Australia, from...
News
- Author:
- Andrew M. Kaunitz, MD
Publish date: April 23, 2020
ACOG gives examples of which patients need in-person appointments, telehealth visits, or visits that should be deferred.
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: April 8, 2020
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: May 17, 2019
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: April 2, 2019
Women with Alzheimer disease (AD) were more likely to have used postmenopausal systemic hormone therapy
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: February 5, 2019
Yes, according to a case-control study that analyzed data from 2 large UK databases in which 80,396 ...
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: January 8, 2019
Secondary analysis of ELITE trial data among 596 women in early (<6 years) and late (≥10 years) p...
Article
- Author:
- Andrew M. Kaunitz, MD
Publish date: December 5, 2018
In older osteopenic women, intravenous zoledronic acid effectively prevents fragility fractures.
